Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand? - Wikidata - wikimedia - TriplyDB

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

http://www.wikidata.org/entity/Q37670532

about

Antimicrobial resistance and virulence characterization of Staphylococcus aureus and coagulase-negative staphylococci from imported beef meat.Antimicrobial Resistance, Biofilm Formation and mecA Characterization of Methicillin-Susceptible S. aureus and Non-S. aureus of Beef Meat Origin in Egypt.Fluoroquinolone-Associated Tendinopathy of the Hand and Wrist: A Systematic Review and Case Report.Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins.Multiple-locus VNTR Analyses of Methicillin-resistant Staphylococcus aureus from Jamaica.In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens.

P2860

Q33654837-307C9442-C36E-42A8-978A-A4BB86F353AE Q36629100-F556C76B-0DAC-4DC8-B0A8-C01938A8ECDF Q39213553-CEB8B8C5-09C1-4EF1-8851-BD87FE8421E9 Q39477521-9C6B7119-F04A-421C-B3EA-8D9FC69F9FFD Q40961288-94153704-BED1-4CF5-B07E-04B3E521EF7E Q52611991-24D0FC1E-6E6A-491E-A76F-212D68DFBAB9 Q53189878-93F5F760-BEA5-48CA-8C69-98DCD23B774F

P2860

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

http://www.wikidata.org/entity/Q37670532

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@en

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@nl

type

label

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@en

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@nl

prefLabel

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@en

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@nl

P1433

Q37670532-4F14DA99-CF13-42DF-AA55-F5A176D9FCD7

P1476

Q37670532-9CDA74AE-68E0-4802-9A8A-B498E977E5C1

P2093

Q37670532-048BB3DE-32BA-42B2-88F5-6D0530EC3EEF

Q37670532-0910FAD8-8F28-466B-81D2-E758FE380D63

P2860

Q37670532-02EE8480-2D43-4C27-BDFB-8E81E6869DB6

Q37670532-17C0AFBE-7761-4E9D-A6B9-CD26F7A1E8D6

Q37670532-206A75A0-0551-46F2-8096-D1F8D714B602

Q37670532-462DE77B-A989-4EDA-895E-6D7E4AF307CD

Q37670532-51531D7E-3782-4DD5-BC15-7217E3F6F3D2

Q37670532-61E14129-515C-4C45-9F20-830E5BFA027E

Q37670532-89510032-2117-4397-9339-DBFC3BDAA326

Q37670532-A99AB07A-4FE9-40F2-B025-3F8750CAA2AE

Q37670532-BE3C02D2-2D74-4278-BC0F-ECE30FA55AC0

Q37670532-BF2037E6-17CC-4962-A31A-D975DD9D1A69

P304

Q37670532-19719ADC-2190-46AA-A2B7-6B8312DADD56

P31

Q37670532-F53CAEE4-AC39-4427-943A-92326AE7CF56

P356

Q37670532-A2E848A8-B5B2-454F-98E8-071617914EC0

P433

Q37670532-991821D1-5F00-48F0-AA3C-E9F5D4D8001B

P478

Q37670532-D8851556-2BBC-429D-B0B8-15751C6F66D4

P577

Q37670532-1C144B74-1F70-4B61-B34E-F50AD0F40A5A

P698

Q37670532-708AD6A2-2E06-4654-8B45-B2652FEFF1BB

P932

Q37670532-C38AC490-985A-4B41-B1A6-57268042010F

P356

0974-2727.119862

P1433

Journal of Laboratory Physicians

P1476

Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?

@en

P2093

Mohiuddin S Qazi

http://www.w3.org/2001/XMLSchema#string

Neeta D Gade

http://www.w3.org/2001/XMLSchema#string

P2860

The changing epidemiology of Staphylococcus aureus?

Methicillin-resistant Staphylococcus aureus: prevalence and current susceptibility pattern in sikkim

High prevalence of multidrug-resistant MRSA in a tertiary care hospital of northern India.

Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.

Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.

In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar

Typing of Methicillin resistant Staphylococcus aureus: a technical review.

Ciprofloxacin resistance in methicillin- and gentamicin-resistant Staphylococcus aureus.

Prevalence and Antimicrobial Susceptibility Pattern of Methicillin-resistant Staphylococcus Aureus [MRSA] Isolates at a Tertiary Care Hospital in Mangalore, South India.

Characterisation of methicillin resistant S. aureus strains and risk factors for acquisition in a teaching hospital in northeast India.

P304

109-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0974-2727.119862

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24701103

http://www.w3.org/2001/XMLSchema#string

P932

3968619

http://www.w3.org/2001/XMLSchema#string